This course has expired. View available courses.
Endocrinology
Webinar: Addressing Three Clinical Questions in Diabetes
The evidence regarding the management of type 2 diabetes is continually evolving. As this evidence evolves, there are issues that arise where the clinician can consider multiple pathways for the management of patients. Three issues that are currently being debated will be addressed within this webinar. It will review the evidence supporting diabetes remission at diagnosis versus regulation, the debate of glycemic control versus cardiovascular risk reduction and the role of continuous glucose monitoring as a potentially preferred method of monitoring over HbA1c measurement. The international expert panel will review the current evidence and share their insight on each of these issues so that their colleagues can integrate the evidence into their clinical practice.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
Unaccredited
EXPIRY DATE
2024-03-20
The evidence regarding the management of type 2 diabetes is continually evolving. As this evidence evolves, there are issues that arise where the clinician can consider multiple pathways for the management of patients. Three issues that are currently being debated will be addressed within this webinar. It will review the evidence supporting diabetes remission at diagnosis versus regulation, the debate of glycemic control versus cardiovascular risk reduction and the role of continuous glucose monitoring as a potentially preferred method of monitoring over HbA1c measurement. The international expert panel will review the current evidence and share their insight on each of these issues so that their colleagues can integrate the evidence into their clinical practice.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
Faculty
David Strain, BSc(Hons), MB. ChB., MRCP(UK), MD, FRCP(London)
Matthias Blüher, MD
Alice Cheng, MD
Celine Huot, MD, FRCPC
Roopa Mehta, MBBS, MRCP
Saud Al Sifri, MD, FACE
Learning objectives
Upon successful completion of this continuing education module, the participant will be better able to:
- Discuss the evidence for remission of diabetes
- Initiate diabetes treatment in newly-diagnosed patients with type 2 diabetes, according to the Diabetes Canada guidelines
- Start a conversation with patients to enable shared decision making for treatment initiation
- Individualize treatment according to patient concerns and priorities
Accreditation
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
1 hr
Duration
Specialist
Profession
1
# of credits
Learning Objectives
Upon successful completion of this continuing education module, the participant will be better able to:
- Discuss the evidence for remission of diabetes
- Initiate diabetes treatment in newly-diagnosed patients with type 2 diabetes, according to the Diabetes Canada guidelines
- Start a conversation with patients to enable shared decision making for treatment initiation
- Individualize treatment according to patient concerns and priorities
Unaccredited
ACCREDITATION
Endocrinology
Learning Category
General
Topic
0
Price
2024-03-20
Expiry Date
EU
Region/Language
Course Description
The evidence regarding the management of type 2 diabetes is continually evolving. As this evidence evolves, there are issues that arise where the clinician can consider multiple pathways for the management of patients. Three issues that are currently being debated will be addressed within this webinar. It will review the evidence supporting diabetes remission at diagnosis versus regulation, the debate of glycemic control versus cardiovascular risk reduction and the role of continuous glucose monitoring as a potentially preferred method of monitoring over HbA1c measurement. The international expert panel will review the current evidence and share their insight on each of these issues so that their colleagues can integrate the evidence into their clinical practice.
This program has received an unrestricted educational grant or in-kind support from Novo Nordisk A/S.
Faculty
David Strain, BSc(Hons), MB. ChB., MRCP(UK), MD, FRCP(London)
Matthias Blüher, MD
Alice Cheng, MD
Celine Huot, MD, FRCPC
Roopa Mehta, MBBS, MRCP
Saud Al Sifri, MD, FACE
Accreditation
To be added
1 hr
Duration
0
Price
1
# of credits
